B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses

被引:39
|
作者
Fraussen, Judith [1 ]
Claes, Nele [1 ]
Van Wijmeersch, Bart [1 ,2 ]
van Horssen, Jack [1 ,3 ]
Stinissen, Piet [1 ]
Hupperts, Raymond [4 ,5 ]
Somers, Veerle [1 ]
机构
[1] Univ Limburg, Hasselt Univ, Sch Life Sci, Biomed Res Inst & Transnat, Diepenbeek, Belgium
[2] Revalidat & MS Ctr, Overpelt, Belgium
[3] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands
[4] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Maastricht, Netherlands
[5] Acad MS Ctr Limburg, Zuyderland Med Centrum, Sittard, Netherlands
关键词
Multiple sclerosis; B cells; Antigen presentation; Costimulatory molecules; T cells; MYELIN BASIC-PROTEIN; CEREBROSPINAL-FLUID; HELPER TYPE-1; ACTIVATION; CYTOKINE; B7-2; RITUXIMAB; DEPLETION; DISEASE; SUBSET;
D O I
10.1016/j.clim.2016.10.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibody-independent B cell functions play an important role in multiple sclerosis (MS) pathogenesis. In this study, B cell antigen presentation and costimulation in MS were studied. Peripheral blood B cells of MS patients showed increased expression of costimulatory CD86 and CD80 molecules compared with healthy controls (HC). In MS cerebrospinal fluid (CSF), 12-fold and 2-fold increases in CD86(+) and CD80 B cells, respectively, were evidenced compared with peripheral blood. Further, B cells from MS patients induced proinflammatory T cells in response to myelin basic protein (MBP). Immunomodulatory treatment restored B cell costimulatory molecule expression and caused significantly reduced B cell induced T cell responses. Together, these results demonstrate the potential of B cells from MS patients to induce autoreactive proinflammatory T cell responses. Immunomodulatory therapy abrogated this effect, emphasizing the importance of B cell antigen presentation and costimulation in MS pathology. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 132
页数:9
相关论文
共 50 条
  • [1] Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination
    Hermans, G
    Denzer, U
    Lohse, A
    Raus, J
    Stinissen, P
    JOURNAL OF AUTOIMMUNITY, 1999, 13 (02) : 233 - 246
  • [2] Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis
    Gregory, GD
    Robbie-Ryan, M
    Secor, VH
    Sabatino, JJ
    Brown, MA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (12) : 3478 - 3486
  • [3] Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis
    de Jong, H.
    Berlo, S. E.
    Hombrink, P.
    Otten, H. G.
    van Eden, W.
    Lafeber, F. P.
    Heurkens, A. H. M.
    Bijlsma, J. W. J.
    Glant, T. T.
    Prakken, B. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 255 - 262
  • [4] Vaccination with autoreactive T cells in the treatment of Multiple Sclerosis
    Correale, J
    MEDICINA-BUENOS AIRES, 2000, 60 (05) : 722 - 722
  • [5] Phenotypic characterization of autoreactive T cells in multiple sclerosis
    Ratts, Robert B.
    Karandikar, Nitin J.
    Hussain, Rehana Z.
    Choy, Judy
    Northrop, Sara C.
    Lovett-Racke, Amy E.
    Racke, Michael K.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 (1-2) : 100 - 110
  • [6] γδ T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination
    Stinissen, P
    Zhang, JW
    Vandevyver, C
    Hermans, G
    Raus, J
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) : 94 - 104
  • [7] Emergence of proinflammatory autoreactive T-cell responses in preclinical rheumatoid arthritis
    Aslam, Aamir
    Nam, Jackie
    Hunt, Laura
    Rakieh, Chadi
    Morgan, Ann
    Emery, Paul
    LANCET, 2014, 383 : 22 - 22
  • [8] Antigen recognition patterns of autoreactive T cells in multiple sclerosis
    Martin, R
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 11 - 11
  • [9] Longitudinal analysis of autoreactive T cells in a cohort of multiple sclerosis patients treated with natalizumab
    Willekens, B.
    Wens, I.
    Reynders, T.
    van den Bos, J.
    van Delen, M.
    Peeters, S.
    Costas-Romero, C.
    Berneman, Z.
    Cras, P.
    Cools, N.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 531 - 532
  • [10] Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation
    Scholz, C
    Patton, KT
    Anderson, DE
    Freeman, GJ
    Hafler, DA
    JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1532 - 1538